Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway-Reference-Cited by-同舟云学术

Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

Published:2013-02-22 Issue:2 Volume:108 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Chen Ke,Gao Lu,Liu Yu,Zhang Yan,Jiang Ding-Sheng,Wei Xiang,Zhu Xue Hai,Zhang Rui,Chen Yingjie,Yang Qinglin,Kioka Noriyuki,Zhang Xiao-Dong,Li Hongliang

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-013-0338-0.pdf

Reference44 articles.

1. Akamatsu M, Aota S, Suwa A, Ueda K, Amachi T, Yamada KM, Akiyama SK, Kioka N (1999) Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activities. J Biol Chem 274:35933–35937. doi: 10.1074/jbc.274.50.35933

2. Bian Z, Cai J, Shen DF, Chen L, Yan L, Tang Q, Li H (2009) Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis. J Cell Mol Med 13:1302–1313. doi: 10.1111/j.1582-4934.2008.00633.x

3. Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD (2003) Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 111:1475–1486. doi: 10.1172/jci200317295

4. Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, Barreto-Chaves ML (2010) Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 105:325–335. doi: 10.1007/s00395-010-0089-0

5. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, Latronico MV, Napoli C, Sadoshima J, Croce CM, Ross J Jr (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99:12333–12338. doi: 10.1073/pnas.172376399

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα;Cell Death & Disease;2020-02

2. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation;Biomedicine & Pharmacotherapy;2020-01

3. Novel Role for Pleckstrin Homology‐Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy;Journal of the American Heart Association;2019-08-20

4. Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway;Journal of Cellular and Molecular Medicine;2018-11-22

5. Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy;Frontiers in Genetics;2018-08-21